We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 61-80 of 659 results
  1. An international multidisciplinary consensus statement on MAFLD and the risk of CVD

    Background

    Fatty liver disease in the absence of excessive alcohol consumption is an increasingly common condition with a global prevalence...

    **ao-Dong Zhou, Giovanni Targher, ... Ming-Hua Zheng in Hepatology International
    Article 19 May 2023
  2. Diagnosis of monoclonal immunotactoid glomerulopathy with positive λ chain by immunoelectron microscopy

    We report the case of a 73-year-old-man who developed immunotactoid glomerulopathy (ITG). ITG is a rare disease characterized by proliferative...

    Erina Sugita, Homare Sonoda, ... Hiroshi Itoh in CEN Case Reports
    Article 14 June 2022
  3. Enhanced tryptophan-kynurenine metabolism via indoleamine 2,3-dioxygenase 1 induction in dermatomyositis

    Objectives

    Extrahepatic tryptophan (Trp)-kynurenine (Kyn) metabolism via indoleamine 2,3-dioxygenase 1 (IDO1) induction was found to be associated...

    Dan Wu, Mengya Chen, ... Hua Cao in Clinical Rheumatology
    Article Open access 01 July 2022
  4. Homeostasis and dyshomeostasis of the retina

    Retinal homeostasis is maintained through a network of the nervous, circulatory, endocrine and immune systems. The integrity of the blood-retinal...

    Chang-Jun Zhang, Zi-Bing ** in Current Medicine
    Article Open access 06 May 2023
  5. A genetic variant c.553G > T (rs2075291) in the apolipoprotein A5 gene is associated with altered triglycerides levels in coronary artery disease (CAD) patients with lipid lowering drug

    Background

    Elevated plasma triglycerides (TGs) are widely used as a major cardiovascular risk predictor and are thought to play an important role in...

    Neda M. Bogari, Ashwag Aljohani, ... Ahmed Fawzy in BMC Cardiovascular Disorders
    Article Open access 03 January 2019
  6. Targeting innate immunity-driven inflammation in CKD and cardiovascular disease

    Mortality among patients with chronic kidney disease (CKD) is largely a consequence of cardiovascular disease (CVD) and is a particular concern given...

    Thimoteus Speer, Stefanie Dimmeler, ... Paul M Ridker in Nature Reviews Nephrology
    Article 05 September 2022
  7. Isoform-dependent APOE secretion modulates neuroinflammation

    Philip Hasel, Shane A. Liddelow in Nature Reviews Neurology
    Article 16 March 2021
  8. Signaling pathways of chronic kidney diseases, implications for therapeutics

    Chronic kidney disease (CKD) is a chronic renal dysfunction syndrome that is characterized by nephron loss, inflammation, myofibroblasts activation,...

    Qian Yuan, Ben Tang, Chun Zhang in Signal Transduction and Targeted Therapy
    Article Open access 09 June 2022
  9. Egyptian practical guidance in hypertriglyceridemia management 2021

    Hypertriglyceridemia (HTG) is a very common, yet underappreciated problem in clinical practice. Elevated triglyceride (TG) levels are independently...

    Hesham Salah El Din Taha, Hossam Kandil, ... Mirna Mamdouh Shaker in The Egyptian Heart Journal
    Article Open access 20 December 2021
  10. The rationale and study design of two phase II trials examining the effects of BI 685509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosis

    Background

    Clinically significant portal hypertension (CSPH) drives cirrhosis-related complications (i.e. hepatic decompensation). Impaired nitric...

    Thomas Reiberger, Annalisa Berzigotti, ... Andrea Tomisser in Trials
    Article Open access 24 April 2023
  11. Glycosylation and its research progress in endometrial cancer

    Endometrial cancer (EC) is one of the most common tumors in the female reproductive system, which seriously threatens women's health, particularly in...

    Congli Pu, Biyuan, ... Yingchao Zhao in Clinical and Translational Oncology
    Article Open access 25 June 2022
  12. Is podocytopathy another image of renal affection in p-SLE?

    Background

    Lupus podocytopathy (LP) is a renal affection described in systemic lupus erythematosus (SLE) patients with nephrotic range proteinuria,...

    Hend H. Abdelnabi in Pediatric Rheumatology
    Article Open access 26 April 2021
  13. Repurposing drugs against Alzheimer’s disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?

    Therapeutic approaches providing effective medication for Alzheimer’s disease (AD) patients after disease onset are urgently needed. Previous studies...

    Volkmar Leßmann, Georgia-Ioanna Kartalou, ... Kurt Gottmann in Journal of Neural Transmission
    Article Open access 04 April 2023
  14. Pathogenesis of autoimmune disease

    Autoimmune diseases are a diverse group of conditions characterized by aberrant B cell and T cell reactivity to normal constituents of the host....

    David S. Pisetsky in Nature Reviews Nephrology
    Article 10 May 2023
  15. Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group

    The increasing global incidence of obesity and type 2 diabetes mellitus (T2D) underscores the urgency of addressing these interconnected health...

    Andrej Janez, Emir Muzurovic, ... Manfredi Rizzo in Diabetes Therapy
    Article Open access 11 July 2024
  16. Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis

    Purpose of Review

    We discuss current controversies in the clinical use of omega-3 fatty acids (FA), primarily eicosapentaenoic acid (EPA) and...

    Renato Quispe, Abdulhamied Alfaddagh, ... Seth S. Martin in Current Atherosclerosis Reports
    Article 30 April 2022
  17. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary

    Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcoholic fatty liver disease (NAFLD), is defined as...

    Frank Tack, Paul Horn, ... Dror Dicker in Diabetologia
    Article 13 June 2024
  18. Cellular and Molecular Mechanisms of Mast Cells in Atherosclerotic Plaque Progression and Destabilization

    Mast cells (MCs) are commonly recognized for their crucial involvement in the pathogenesis of allergic diseases, but over time, it has come to light...

    Daniel Elieh-Ali-Komi, Ilze Bot, ... Marcus Maurer in Clinical Reviews in Allergy & Immunology
    Article Open access 30 January 2024
  19. Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics

    Disturbed cholesterol homeostasis plays critical roles in the development of multiple diseases, such as cardiovascular diseases (CVD),...

    Yajun Duan, Ke Gong, ... Jihong Han in Signal Transduction and Targeted Therapy
    Article Open access 02 August 2022
  20. Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects

    Pediatric antiphospholipid syndrome (APS) is a rare acquired multisystem autoimmune thromboinflammatory condition characterized by thrombotic and...

    Aline Garcia Islabão, Vitor Cavalcanti Trindade, ... Clovis Artur Silva in Pediatric Drugs
    Article 13 December 2021
Did you find what you were looking for? Share feedback.